112 related articles for article (PubMed ID: 8691618)
1. [Tumor markers: neoplasmas in digestive organs].
Takami H; Kodaira S
Nihon Rinsho; 1996 Jun; 54(6):1616-20. PubMed ID: 8691618
[TBL] [Abstract][Full Text] [Related]
2. [Tumor markers--personal experience. The use of tumor markers for cancer of digestive organs].
Ishii M
Gan To Kagaku Ryoho; 1991 May; 18(6):1059-65. PubMed ID: 1709347
[TBL] [Abstract][Full Text] [Related]
3. [Tumor markers in cancer of the digestive system].
Zinser JW
Rev Gastroenterol Mex; 1997; 62(3):145-8. PubMed ID: 9480520
[TBL] [Abstract][Full Text] [Related]
4. [Biomarkers for neoplasmas in digestive organs].
Iwasaki Y; Arai K; Katayanagi S; Takahashi K; Yamaguchi T; Matsumoto H; Miyamoto H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1015-20. PubMed ID: 15272578
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of serum CA 19-9 determination in digestive tract cancer].
Chen SB
Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):58-60. PubMed ID: 2364873
[TBL] [Abstract][Full Text] [Related]
6. [The clinical value of tumor marker CA50 and CA242 in digestive tract cancer].
Huang C; Bei L; Liu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Aug; 20(4):285-8. PubMed ID: 11367693
[TBL] [Abstract][Full Text] [Related]
7. The des-gamma-carboxyprothrombin for the diagnosis of hepatocellular carcinoma.
Brunello F; Marcarino C; Pasquero P; Gastaldi P; Gonella S; Martini S; Calcamuggi G; Emanuelli G
Ital J Gastroenterol; 1993 Jan; 25(1):9-12. PubMed ID: 7679014
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of serum TAC-41 in various digestive cancers].
Sato S; Yamanaka T; Kimura K
Rinsho Byori; 1989 Nov; 37(11):1259-62. PubMed ID: 2601083
[TBL] [Abstract][Full Text] [Related]
9. [The clinical applications of serum tumor markers in gastroenterology].
González Martínez M; Marín López E
Rev Gastroenterol Mex; 1993; 58(2):103-7. PubMed ID: 7747020
[TBL] [Abstract][Full Text] [Related]
10. Early diagnosis of hepatocellular carcinoma using a sensitive assay for serum des-gamma-carboxy prothrombin: a prospective study.
Ikoma J; Kaito M; Ishihara T; Nakagawa N; Kamei A; Fujita N; Iwasa M; Tamaki S; Watanabe S; Adachi Y
Hepatogastroenterology; 2002; 49(43):235-8. PubMed ID: 11941963
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic significance of carbohydrate antigen CA 19-9 in serum and pancreatic juice in pancreatic carcinoma.
Chen YF; Mai CR; Tie ZJ; Feng ZT; Zhang J; Lu XH; Lu GJ; Xue YH; Pan GZ
Chin Med J (Engl); 1989 May; 102(5):333-7. PubMed ID: 2509154
[TBL] [Abstract][Full Text] [Related]
12. [Tumor markers in hepatoma, gallbladder-biliary tract and pancreas cancer].
Nakahara M; Fujisawa K
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3010-9. PubMed ID: 2445292
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of the analysis of alpha fetoprotein levels in malignant neoplasms of the digestive system].
Pardela M; Buntner B; Ostrowska Z; Wylezoł M; Kozłowski A; Piecuch J; Zbroński R
Wiad Lek; 1992 Aug; 45(15-16):593-6. PubMed ID: 1283234
[TBL] [Abstract][Full Text] [Related]
15. Detection of serum tumor markers in the diagnosis and treatment of patients with pancreatic cancer.
Jiang XT; Tao HQ; Zou SC
Hepatobiliary Pancreat Dis Int; 2004 Aug; 3(3):464-8. PubMed ID: 15313690
[TBL] [Abstract][Full Text] [Related]
16. [Serological test of carbohydrate antigen CA50 in patients with cancer of the digestive tract].
Takami H; Furuuchi T; Ogata Y; Abe O
Gan To Kagaku Ryoho; 1987 Feb; 14(2):495-501. PubMed ID: 3468885
[TBL] [Abstract][Full Text] [Related]
17. [Urine diacetylspermine as a novel tumor marker].
Yamaguchi K; Kaku T; Enjoji M; Kato M; Anai M; Kawakita M; Hamasaki N; Tanaka M
Rinsho Byori; 2005 Feb; 53(2):130-5. PubMed ID: 15796046
[TBL] [Abstract][Full Text] [Related]
18. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers for pancreatic and biliary tract cancer].
Takezako Y; Okusaka T; Ueno H; Ikeda M; Morizane C; Najima M
Gan To Kagaku Ryoho; 2004 Sep; 31(9):1443-6. PubMed ID: 15446574
[TBL] [Abstract][Full Text] [Related]
20. Serum des-gamma-carboxyprothrombin level by a modified enzyme immunoassay method in hepatocellular carcinoma: clinical significance in small hepatocellular carcinoma.
Soga K; Watanabe T; Aikawa K; Toshima M; Shibasaki K; Aoyagi Y
Hepatogastroenterology; 1998; 45(23):1737-41. PubMed ID: 9840138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]